Lawrence Waldman - Aug 8, 2024 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role: Director
Signature: /s/ Lawrence Waldman
Stock symbol: APYX
Transactions as of: Aug 8, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/12/2024, 04:50 PM
Previous filing: Aug 15, 2023
Next filing: Aug 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APYX	Stock Option (Option to Buy)	Award	$0	-17K	-50%	$0.00	17K	Aug 8, 2024	Common Stock	17K	$1.02	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Content

Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.